MTVA MetaVia Inc.
Company Analysis
Latest News
π’ MetaVia is trading 5% up today on continued momentum for its obesity and cardiometabolic drug programs
MetaVia is trading 5% up at $1.87 amid continued interest in its obesity and cardiometabolic drug programs. β’ Recent gains follow late-breaking abstract...
π’ MetaVia is trading 10.1% up
MetaVia is trading at $1.72, up 10.1% from a comparison close of $1.56 during regular trading. This is a price-action follow-up, so a separate catalyst may not...
π’ MetaVia Soars 5.1% After Announcing Completion of Dose Titration in Phase 1 Part 3 Obesity Study
β’ MetaVia Inc. (MTVA) shares are up 5.1% today, trading at $1.64. β’ The company announced successful completion of dose titration for all active patients in...
π΄ MTVA is trading 5.1% down today on profit-taking after a multi-day bounce
MTVA is trading at $1.50 (down 5.1%) as the stock pulls back following a strong multi-day rally that saw shares close at $1.58 on July 07, 2026. β’ The decline...
π’ MTVA is trading 6.62% up today with no clear company-specific catalyst
MTVA is trading at $1.61 (6.62%) up today despite a lack of clearly identified company-specific news or catalysts in available sources. β’ The stock is...
MetaVia expands stock offering to $4 million, seeking major capital boost
MetaVia Inc. increased its at-the-market equity program to allow for the sale of up to $4 million in common stock. The clinical-stage biotechnology company...
π΄ MTVA is trading 5.4% down today as shares pull back from a short-term rebound
MTVA is trading 5.4% down at $1.41 as shares pull back from a short-term rebound. β’ The decline appears to be driven by normal volatility and profit-taking...
π΄ MTVA is trading 6.5% down today as it pulls back from a recent rebound
MTVA is trading 6.5% down at $1.39 in thin pre-market activity, pulling back after a recent rebound that saw the stock close at $1.49 on June 29. β’ There are...
π’ MTVA is trading 6.2% up today on broader market rebound and technical buying
MTVA is trading 6.2% up at $1.52 today, moving broadly in line with a strong rebound in major U.S. indices following recent weakness. β’ The upward move...
π΄ MTVA is trading 6.3% down today with no clear catalyst identified
MTVA is trading 6.3% down at $1.47 in pre-market trading with no clear catalyst identified for the move. β’ The decline extends recent downside volatility...
π΄ MetaVia Inc. is trading 4.1% down today
MetaVia Inc. is trading at $1.53 (-4.06%) with no clear company-specific catalyst identified from available news coverage. β’ The stockβs recent weakness...
π΄ MetaVia Inc. is trading 5.6% down today amid post-Fed risk-off pressure and rising yields
MetaVia Inc. is trading 5.6% down at $1.61 as a post-Fed risk-off tone continues to weigh on speculative small-cap biotech names. β’ The stock experienced a...
π΄ MetaVia Inc. is trading 6.4% down today amid a broader post-Fed risk-off tone and market weakness
MetaVia Inc. is trading at $1.60 (-6.43%) in pre-market following a broader post-Fed risk-off tone that has pressured major indices and futures. β’ The...
π΄ MetaVia Inc. is trading 5.3% down today following broader market decline and Fed's hawkish stance; company announced upcoming investor forum
MetaVia Inc. is trading at $1.62 (5.3% down) in after-hours trading. The stock declined from a regular-session close of $1.71**, amidst a broader market...
π’ MetaVia Inc. is trading 7.5% up today amid a tech-led market rebound and easing U.S.-Iran tensions
MetaVia Inc. is trading 7.5% up today at $1.87 amid a strong, tech-led market rebound and improved risk appetite. β’ Major indices are trending higher, with...
π΄ MetaVia Inc. makes sharp 10.2% drop
MTVA is trading at $1.80, down 10.2% versus the comparison close of $2.01 during regular trading. This is a price-movement alert; no separate company-specific...
π΄ MetaVia Inc. is trading 5.5% down today as traders lock in profits after obesity pipeline rally
MetaVia Inc. is trading 5.5% down today at $1.90 as the stock retraces sharp gains driven by recent obesity and cardiometabolic pipeline headlines. β’ The...
π΄ MetaVia Inc. is trading 6.1% down today as early enthusiasm for obesity pipeline update fades
MetaVia Inc. is trading at $1.84 (6.1% down) as initial gains tied to its obesity and metabolic pipeline update faded during regular trading. β’ Investors were...
π’ MetaVia Inc. (MTVA) shares rise 8.7% ahead of conference presentation
MetaVia Inc. is trading at $2.13 (up 8.7%) in pre-market action as investors anticipate a company update on its key drug pipeline later today. β’ The company...
π΄ MetaVia Inc. is trading 5% down today as dilution fears persist following reverse split approval
MetaVia Inc. is trading 5% down at $1.79 as traders react to last weekβs shareholder approval of a reverse stock split and an expanded equity incentive...